Yong-Man Kim

18PUBLICATIONS
83CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Other Asian languages (excl. South-East Asian)Other biomedical and clinical sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 13, 2026
Dual PARP/Tankyrase Inhibition Enhances Antitumor Efficacy in PTEN-Deficient Endometrial Cancer.

|May 25, 2026
Clinical significance of circulating tumor DNA monitoring based on TP53 mutation in high-grade serous ovarian cancer patients.

|Jul 04, 2025
Oncogenic pathway landscape of ovarian cancer and correlation with clinical prognosis.

Young-Jae Lee, Na-Eun Kim, Jung-Hyun Bae

|Jul 01, 2025
Pembrolizumab plus chemotherapy with or without bevacizumab in East Asian participants with persistent, recurrent, or metastatic cervical cancer: results from KEYNOTE-826 final analysis.

Yong-Man Kim, Shin Nishio, Se Ik Kim

|Oct 03, 2024
Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005.

Jung-Min Lee, Mark F Brady, Austin Miller

|Apr 12, 2024
Current treatment strategies for ovarian cancer in the East Asian Gynecologic Oncology Trial Group (EAGOT).

Yusuke Kobayashi, Muneaki Shimada, Masato Tamate

Pageof 3

Frequent Collaborators

9 joint publications

Shin-Wha Lee

7 joint publications

Young-Jae Lee

5 joint publications

Jeong-Yeol Park

5 joint publications

Young-Tak Kim